Aprile, V.; Lenzini, A.; Lococo, F.; Bacchin, D.; Korasidis, S.; Mastromarino, M.G.; Guglielmi, G.; Palmiero, G.; Ambrogi, M.C.; Lucchi, M.
Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment. J. Clin. Med. 2021, 10, 3801.
https://doi.org/10.3390/jcm10173801
AMA Style
Aprile V, Lenzini A, Lococo F, Bacchin D, Korasidis S, Mastromarino MG, Guglielmi G, Palmiero G, Ambrogi MC, Lucchi M.
Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment. Journal of Clinical Medicine. 2021; 10(17):3801.
https://doi.org/10.3390/jcm10173801
Chicago/Turabian Style
Aprile, Vittorio, Alessandra Lenzini, Filippo Lococo, Diana Bacchin, Stylianos Korasidis, Maria Giovanna Mastromarino, Giovanni Guglielmi, Gerardo Palmiero, Marcello Carlo Ambrogi, and Marco Lucchi.
2021. "Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment" Journal of Clinical Medicine 10, no. 17: 3801.
https://doi.org/10.3390/jcm10173801
APA Style
Aprile, V., Lenzini, A., Lococo, F., Bacchin, D., Korasidis, S., Mastromarino, M. G., Guglielmi, G., Palmiero, G., Ambrogi, M. C., & Lucchi, M.
(2021). Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment. Journal of Clinical Medicine, 10(17), 3801.
https://doi.org/10.3390/jcm10173801
